BLENREP 70 mg powder for concentrate for solution for infusion
- Licence status
- Active substances
- Belantamab Mafodotin
- Dosage Form
- Powder for concentrate for solution for infusion
- Licence number
- EU/1/25/1948/001
- Licence holder
- GlaxoSmithKline Trading Services Limited
Product documents
Licence information
- ATC code
- QL01FX15 belantamab mafodotin
- Legal supply status
- *** AWAITING VALUE ***
- Place of sale
- Marketing availability
- Unknown
- Advertising conditions
- *** AWAITING VALUE ***
- Licence issued